References
Ukena C, Mahfoud F, Kindermann M, Graber S, Kindermann I, Schneider M, Schmieder R, Bramlage P, Volpe M, Thoenes M, Bohm M (2010) Smoking is associated with a high prevalence of microalbuminuria in hypertensive high-risk patients: data from i-search. Clin Res Cardiol 99:825–832
Sargent JD, Demidenko E, Malenka DJ, Li Z, Gohlke H, Hanewinkel R (2012) Smoking restrictions and hospitalization for acute coronary events in Germany. Clin Res Cardiol 101:227–235
Sherif MA, Nienaber CA, Toelg R, Abdel-Wahab M, Geist V, Schneider S, Senges J, Kuck KH, Tebbe U, Richardt G (2011) Impact of smoking on the outcome of patients treated with drug-eluting stents: 1-year results from the prospective multicentre german drug-eluting stent registry (des.De). Clin Res Cardiol 100:413–423
Heitzer T, Just H, Munzel T (1996) Antioxidant vitamin C improves endothelial dysfunction in chronic smokers. Circulation 94:6–9
Weinblatt E, Shapiro S, Frank CW, Sager RV (1968) Prognosis of men after first myocardial infarction: mortality and first recurrence in relation to selected parameters. Am J Public Health Nations Health 58:1329–1347
Kelly TL, Gilpin E, Ahnve S, Henning H, Ross J Jr (1985) Smoking status at the time of acute myocardial infarction and subsequent prognosis. Am Heart J 110:535–541
Barbash GI, White HD, Modan M, Diaz R, Hampton JR, Heikkila J, Kristinsson A, Moulopoulos S, Paolasso EA, Van der Werf T et al (1993) Significance of smoking in patients receiving thrombolytic therapy for acute myocardial infarction. Experience gleaned from the international tissue plasminogen activator/streptokinase mortality trial. Circulation 87:53–58
Robinson K, Conroy RM, Mulcahy R (1988) Smoking and acute coronary heart disease: a comparative study. Br Heart J. 60:465–469
Lisi M, Oelze M, Dragoni S, Liuni A, Steven S, Luca MC, Stalleicken D, Munzel T, Laghi-Pasini F, Daiber A, Parker JD, Gori T (2012) Chronic protection against ischemia and reperfusion-induced endothelial dysfunction during therapy with different organic nitrates. Clin Res Cardiol 101:453–459
Skyschally A, Schulz R, Heusch G (2008) Pathophysiology of myocardial infarction: protection by ischemic pre- and postconditioning. Herz. 33:88–100
Hausenloy DJ, Candilio L, Laing C, Kunst G, Pepper J, Kolvekar S, Evans R, Robertson S, Knight R, Ariti C, Clayton T, Yellon DM (2012) Effect of remote ischemic preconditioning on clinical outcomes in patients undergoing coronary artery bypass graft surgery (ERICCA): Rationale and study design of a multi-centre randomized double-blinded controlled clinical trial. Clin Res Cardiol 101:339–348
Laude K, Thuillez C, Richard V (2002) Peroxynitrite triggers a delayed resistance of coronary endothelial cells against ischemia–reperfusion injury. Am J Physiol Heart Circul Physiol 283:H1418–H1423
Ferdinandy P, Schulz R (2003) Nitric oxide, superoxide, and peroxynitrite in myocardial ischaemia–reperfusion injury and preconditioning. Br J Pharmacol 138:532–543
Altup S, Demiryurek AT, Ak D, Tungel M, Kanzik I (2001) Contribution of peroxynitrite to the beneficial effects of preconditioning on ischaemia-induced arrhythmias in rat isolated hearts. Eur J Pharmacol 415:239–246
Gori T, Di Stolfo G, Sicuro S, Dragoni S, Lisi M, Forconi S, Parker JD (2007) Nitroglycerin protects the endothelium from ischaemia and reperfusion: human mechanistic insight. Br J Clin Pharmacol 64:145–150
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Lisi, M., Dragoni, S., Leone, M.C. et al. Acute (but not chronic) smoking paradoxically protects the endothelium from ischemia and reperfusion: insight into the “smoking paradox”. Clin Res Cardiol 102, 387–389 (2013). https://doi.org/10.1007/s00392-013-0540-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00392-013-0540-y